Found 15 matching trials
WISE CVD - Continuation (WISE HFpEF) N/A The Women's Ischemia Study Evaluation (WISE), a cohort study of over 1000 w...
Show More Location
Cedars-Sinai Women's Heart Center
Learn More & Join Trial
Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC) PHASE2 This clinical study is in subjects who are 18 years old or older with local...
Show More Location
Mayo Clinic - Arizona
Learn More & Join Trial
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery PHASE2 This randomized phase II/III trial studies how well pazopanib, when combine...
Show More Location
Children's Hospital of Alabama
Learn More & Join Trial
Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC PHASE3 This multicenter, prospective, randomized, controlled, open-label, two-arm ...
Show More Location
Jinan, Shandong 0531
Learn More & Join Trial
BOAT: Beta Blocker Uptitration With OptiVol After Cardiac Resynchronization Therapy (CRT) PHASE4 Many heart failure patients are unable to reach target beta blocker doses. ...
Show More Location
St. Lukes Roosevelt Hospital
Learn More & Join Trial
Window of Opportunity in Preserving Laryngeal Function Trial PHASE2 This trial will study the safety and tolerability and disease survival rate...
Show More Location
UPMC Hillman Cancer
Learn More & Join Trial
CARE-HF Long Term Follow-up N/A The CARE-HF long-term follow-up trial evaluates the effects of cardiac resy...
Show More Location
Hull Royal Infirmary - Academic Cardiology Unit
Learn More & Join Trial
Assessment of Ventricular Arrhythmia Risk After CRT-D Replacement for Patients With Primary Prevention Indication N/A Cardiac resynchronization therapy (CRT) has been shown to reduce heart fail...
Show More Learn More & Join Trial
Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC PHASE2 The purpose of this study is to learn more about a drug called Vorinostat (...
Show More Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Learn More & Join Trial
Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding CRT Patients PHASE4 The primary objective of this study is to demonstrate that in patients with...
Show More Location
Ziekenhuis Oost Limburg
Learn More & Join Trial